United Kingdom Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

United Kingdom Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the UK diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in the UK

Scope

• The report provides diabetes care devices information broken down into detailed categories and segments in United Kingdom.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the diabetes care devices market in United Kingdom.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

• 1 Table of Contents
  • 1.1 1.2 2 Introduction
  • 2.1 What Is This Report About?
• 3 Definitions of Markets Covered in the Report
  • 3.1 Diabetes Care Devices
  • 3.2 Glucose Monitoring Devices
    • 3.2.1 Blood Glucose Meters
    • 3.2.2 Blood Glucose Strips
  • 3.3 Insulin Delivery
    • 3.3.1 Insulin Pens
    • 3.3.2 Insulin Syringes
    • 3.3.3 Insulin Pumps
    • 3.3.4 Traditional Insulin Pump Accessories
• 4 Healthcare Sector Review
  • 4.1 Healthcare Expenditure
  • 4.2 Healthcare Infrastructure
  • 4.3 Healthcare Policy
  • 4.4 United Kingdom Healthcare Trade Statistics
• 5 Regulation System
  • 5.1 Medical Equipment Approval Process
    • 5.1.1 Classification of Medical Devices
    • 5.1.2 Conformity Assessment Process
  • 5.2 Medical Device approval fee
  • 5.3 Post Market Surveillance (PMS)
• 6 Pricing and Reimbursement
  • 6.1 Market Pricing
  • 6.2 Government Policies for Reimbursement
• 7 Distribution Structure
• 8 Diabetes Care Devices In United Kingdom
  • 8.1 Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
  • 8.2 Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
  • 8.3 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2015
  • 8.4 Diabetes Care Devices, United Kingdom, Company Share (2007-2008)
• 9 Glucose Monitoring In United Kingdom
  • 9.1 Glucose Monitoring Overall Revenue (2000-2015)
    • 9.1.1 Blood Glucose Meters Overall Revenue (2000-2015)
  • 9.2 Glucose Monitoring Overall Volume (2000-2015)
    • 9.2.1 Blood Glucose Meters Overall Volume (2000-2015)
  • 9.3 Glucose Monitoring Average Price (2000-2015)
  • 9.4 Glucose Monitoring Distribution Share (2007-2008)
  • 9.5 Glucose Monitoring, United Kingdom, Company Share (2007-2008)
• 10 Insulin Delivery In United Kingdom
  • 10.1 Insulin Delivery Overall Revenue (2000-2015)
    • 10.1.1 Insulin Pens Overall Revenue (2000-2015)
  • 10.2 Insulin Delivery Overall Volume (2000-2015)
    • 10.2.1 Insulin Pens Overall Volume (2000-2015)
  • 10.3 Insulin Delivery Average Price (2000-2015)
  • 10.4 Insulin Delivery Distribution Share (2007-2008)
  • 10.5 Insulin Delivery, United Kingdom, Company Share (2007-2008)
• 11 Overview of Key Companies in United Kingdom Diabetes Care Devices Market
  • 11.1 F. Hoffmann-La Roche Ltd
    • 11.1.1 Company Overview
    • 11.1.2 Value Chain Analysis
    • 11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products
  • 11.2 LifeScan, Inc
    • 11.2.1 Company Overview
    • 11.2.2 LifeScan, Inc. Pipeline Products
  • 11.3 Bayer HealthCare AG
    • 11.3.1 Company Overview
    • 11.3.2 Value Chain Analysis
    • 11.3.3 Bayer HealthCare AG Pipeline Products
  • 11.4 Abbott Laboratories
    • 11.4.1 Company Overview
    • 11.4.2 Value Chain Analysis
    • 11.4.3 Abbott Laboratories Pipeline Products
  • 11.5 Novo Nordisk A/S
    • 11.5.1 Company Overview
    • 11.5.2 Novo Nordisk A/S Pipeline Products
  • 11.6 Becton, Dickinson and Company
    • 11.6.1 Company Overview
    • 11.6.2 Value Chain Analysis
  • 11.7 Eli Lilly and Company
    • 11.7.1 Company Overview
    • 11.7.2 Value Chain Analysis
    • 11.7.3 Eli Lilly and Company Pipeline Products
  • 11.8 Medtronic, Inc
    • 11.8.1 Company Overview
    • 11.8.2 Value Chain Analysis
    • 11.8.3 Medtronic, Inc. Pipeline Products
  • 11.9 ARKRAY, Inc
    • 11.9.1 Company Overview
    • 11.9.2 ARKRAY, Inc. Pipeline Products
  • 11.10 Terumo Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Value Chain Analysis
  • 11.11 Animas Corporation
    • 11.11.1 Company Overview
  • 11.12 Sanofi-Aventis
    • 11.12.1 Company Overview
  • 11.13 Smiths Medical
    • 11.13.1 Company Overview
    • 11.13.2 Value Chain Analysis
• 12 Recent Developments
  • 12.1 Strategy And Business Planning
    • 12.1.1 Mar 25, 2009: Smiths Medical Intents To Stop Selling Deltec Cozmo Insulin Pumps
  • 12.2 Government and Public Interest
    • 12.2.1 Apr 29, 2009: Warning About Failing Insulin Infusion Pump, UK
  • 12.3 Product News
    • 12.3.1 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring System Helps To Improve Patient Care
    • 12.3.2 Feb 03, 2009: Accu-Chek Aviva Nano Designed To Motivate Patients For Self-Management Of Diabetes
• 13 Appendix
  • 13.1 Global Markets Direct Research Methodology
  • 13.2 Coverage
  • 13.3 Secondary Research
  • 13.4 Primary Research
  • 13.5 Models
  • 13.6 Forecasts
  • 13.7 Expert Panel Validation
  • 13.8 Currency Conversion
  • 13.9 Contact Us
  • 13.10 Disclaimer
• 1.1 List of Tables
  • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
  • Table 2: United Kingdom Healthcare Trade Statistics, 2001-2006
  • Table 3: Medical Device Approval Fee in UK, 2006
  • Table 4: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
  • Table 5: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
  • Table 6: Diabetes Care Devices, United Kingdom, Cross-Category Analysis, 2000-2015
  • Table 7: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
  • Table 8: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
  • Table 9: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2015
  • Table 10: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2000-2008
  • Table 11: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2008-2015
  • Table 12: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
  • Table 13: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 14: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 15: Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 16: Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 17: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
  • Table 18: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 19: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Table 20: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Table 21: Glucose Monitoring, United Kingdom, Average Price ($), Historic, 2000-2008
  • Table 22: Glucose Monitoring, United Kingdom, Average Price ($), Forecast, 2008-2015
  • Table 23: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
  • Table 24: Glucose Monitoring, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
  • Table 25: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 26: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 27: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 28: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 29: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
  • Table 30: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 31: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Table 32: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Table 33: Insulin Delivery, United Kingdom, Average Price ($), Historic, 2000-2008
  • Table 34: Insulin Delivery, United Kingdom, Average Price ($), Forecast, 2008-2015
  • Table 35: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
  • Table 36: Insulin Delivery, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
  • Table 37: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
  • Table 38: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
  • Table 39: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area
  • Table 40: LifeScan, Inc. Pipeline Products by Equipment Type
  • Table 41: LifeScan, Inc. Pipeline Products by Development Stage
  • Table 42: LifeScan, Inc. Pipeline Products by Therapy Area
  • Table 43: LifeScan, Inc. Pipeline Products by Clinical Trials
  • Table 44: LifeScan, Inc. Pipeline Products by News Summary
  • Table 45: Bayer HealthCare AG Pipeline Products by Equipment Type
  • Table 46: Bayer HealthCare AG Pipeline Products by Development Stage
  • Table 47: Bayer HealthCare AG Pipeline Products by Therapy Area
  • Table 48: Bayer HealthCare AG Pipeline Products by News Summary
  • Table 49: Abbott Laboratories Pipeline Products by Equipment Type
  • Table 50: Abbott Laboratories Pipeline Products by Development Stage
  • Table 51: Abbott Laboratories Pipeline Products by Therapy Area
  • Table 52: Abbott Laboratories Pipeline Products by Clinical Trials
  • Table 53: Abbott Laboratories Pipeline Products by News Summary
  • Table 54: Novo Nordisk A/S Pipeline Products by Equipment Type
  • Table 55: Novo Nordisk A/S Pipeline Products By Development Stage
  • Table 56: Novo Nordisk A/S Pipeline Products By Therapy Area
  • Table 57: Novo Nordisk A/S Pipeline Products By Clinical Trials
  • Table 58: Eli Lilly and Company Pipeline Products by Equipment Type
  • Table 59: Eli Lilly and Company Pipeline Products by Development Stage
  • Table 60: Eli Lilly and Company Pipeline Products by Therapy Area
  • Table 61: Eli Lilly and Company Pipeline Products by Clinical Trials
  • Table 62: Eli Lilly and Company Pipeline Products by News Summary
  • Table 63: Medtronic, Inc. Pipeline Products by Equipment Type
  • Table 64: Medtronic, Inc. Pipeline Products By Development Stage
  • Table 65: Medtronic, Inc. Pipeline Products By Therapy Area
  • Table 66: Medtronic, Inc. Pipeline Products By Clinical Trials
  • Table 67: Medtronic, Inc. Pipeline Products By News Summary
  • Table 68: ARKRAY, Inc. Pipeline Products by Equipment Type
  • Table 69: ARKRAY, Inc. Pipeline Products by Development Stage
  • Table 70: ARKRAY, Inc. Pipeline Products by Clinical Trials
  • Table 71: ARKRAY, Inc. Pipeline Products by News Summary
  • Table 72: USD to Local Currency, Average Exchange Rate 2008
• 1.2 List of Figures
  • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
  • Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007
  • Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007
  • Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
  • Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
  • Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
  • Figure 7: Flowchart for Classification of Active Devices in UK, 2007
  • Figure 8: Flowchart for Classification of Active Devices in UK, 2007
  • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
  • Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007
  • Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
  • Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
  • Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007
  • Figure 14: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
  • Figure 15: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
  • Figure 16: Diabetes Care Devices, United Kingdom, Cross-Category Analysis, 2000-2015
  • Figure 17: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
  • Figure 18: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
  • Figure 19: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2015
  • Figure 20: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2000-2008
  • Figure 21: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2008-2015
  • Figure 22: Diabetes Care Devices, United Kingdom, Company Share (%), 2008
  • Figure 23: Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 24: Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 25: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Figure 26: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Figure 27: Glucose Monitoring, United Kingdom, Company Share (%), 2008
  • Figure 28: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 29: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 30: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 31: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 32: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Figure 33: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Figure 34: Insulin Delivery, United Kingdom, Company Share (%), 2008
  • Figure 35: F. Hoffmann-La Roche Ltd Value Chain Analysis
  • Figure 36: Bayer HealthCare AG Value Chain Analysis
  • Figure 37: Abbott Laboratories Value Chain Analysis
  • Figure 38: Becton, Dickinson and Company Value Chain Analysis
  • Figure 39: Eli Lilly and Company Value Chain Analysis
  • Figure 40: Medtronic, Inc. Value Chain Analysis
  • Figure 41: Terumo Corporation Value Chain Analysis
  • Figure 42: Smiths Medical Value Chain Analysis
  • Figure 43: Global Markets Direct Methodology